Oxytocin receptor agonists for treatment of social anxiety

催产素受体激动剂治疗社交焦虑

• 批准号: nhmrc : 1033444
• 负责人: A/Pr Glenn Hunt
• 金额: $ 30.66万
• 依托单位: The University of Sydney
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/oxytocin-receptor-agonists-social-anxiety/110892
• 关键词: Oxytocin; receptor; agonists; treatment; social

At any one time, about 3% of the population suffers from crippling social anxiety disorder, characterized by excessive fear of exposure to situations that involve potential scrutiny by others. Current medications for treating social anxiety are of limited use. This project will develop new drug like molecules that could provide breakthroughs in the effective treatment of social anxiety.

在任何时候，大约有3%的人口患有严重的社交焦虑症，其特征是过度害怕暴露在涉及他人潜在审查的情况下。目前治疗社交焦虑症的药物使用有限。该项目将开发新的药物分子，可以在有效治疗社交焦虑方面取得突破。